Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 953891
                    [Title] => Lilly stops mid-stage Alzheimer's drug study
                    [Summary] => 
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

                    [DatePublished] => 2013-06-14 08:00:48
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => http://img10.imageshack.us/img10/3674/8amf.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 867025
                    [Title] => New gene triples risk for Alzheimer's disease
                    [Summary] => 
Scientists have identified a new gene variant that seems to strongly raise the risk for Alzheimer's disease, giving a fresh target for research into treatments for the mind-robbing disorder.

	 

                    [DatePublished] => 2012-11-15 14:22:38
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img690.imageshack.us/img690/3810/alzheimerthumb.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 857745
                    [Title] => Alzheimer drug shows some promise in mild disease
                    [Summary] => 
Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease.
                    [DatePublished] => 2012-10-09 09:32:06
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => http://imageshack.us/a/img856/8255/alzheimersdrug2thumb.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 848170
                    [Title] => Studies: Alzheimer drug may stabilize brain plaque
                    [Summary] => 
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
                    [DatePublished] => 2012-09-12 10:22:35
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 829079
                    [Title] => Small study: Drug may help stabilize Alzheimer's
                    [Summary] => 
For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and found in only four patients.
                    [DatePublished] => 2012-07-18 09:30:28
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

ARICEPT AND NAMENDA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 953891
                    [Title] => Lilly stops mid-stage Alzheimer's drug study
                    [Summary] => 
Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because of potential side effects on patients' livers.

                    [DatePublished] => 2013-06-14 08:00:48
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => http://img10.imageshack.us/img10/3674/8amf.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 867025
                    [Title] => New gene triples risk for Alzheimer's disease
                    [Summary] => 
Scientists have identified a new gene variant that seems to strongly raise the risk for Alzheimer's disease, giving a fresh target for research into treatments for the mind-robbing disorder.

	 

                    [DatePublished] => 2012-11-15 14:22:38
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://img690.imageshack.us/img690/3810/alzheimerthumb.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 857745
                    [Title] => Alzheimer drug shows some promise in mild disease
                    [Summary] => 
Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease.
                    [DatePublished] => 2012-10-09 09:32:06
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => http://imageshack.us/a/img856/8255/alzheimersdrug2thumb.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 848170
                    [Title] => Studies: Alzheimer drug may stabilize brain plaque
                    [Summary] => 
An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.
                    [DatePublished] => 2012-09-12 10:22:35
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 829079
                    [Title] => Small study: Drug may help stabilize Alzheimer's
                    [Summary] => 
For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and found in only four patients.
                    [DatePublished] => 2012-07-18 09:30:28
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

abtest

Lilly stops mid-stage Alzheimer's drug study

June 14, 2013 - 8:00am

Eli Lilly and Co. said Thursday that it stopped a mid-stage clinical trial of an experimental Alzheimer's disease drug because...

World

New gene triples risk for Alzheimer's disease

November 15, 2012 - 2:22pm

Scientists have identified a new gene variant that seems to strongly raise the risk for Alzheimer's disease, giving a...

Health And Family

Alzheimer drug shows some promise in mild disease

October 9, 2012 - 9:32am

Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially...

Studies: Alzheimer drug may stabilize brain plaque

September 12, 2012 - 10:22am

An experimental drug that failed to stop mental decline in Alzheimer's patients in the U.S. and Canada also showed some potential benefit in slowing brain plaque, fuller results of two major studies show.

Small study: Drug may help stabilize Alzheimer's

July 18, 2012 - 9:30am

For the first time, researchers are reporting that a treatment might help stabilize Alzheimer's disease for as much as three years, although the evidence is weak and found in only four patients.